3D Cell Culture Market, by Technology (Extracellular Matrices or Scaffolds, Bioreactors, Gels, Scaffold-free Platforms, and Microchips), by Application (Research, Drug Discovery, Tissue Engineering, Clinical Applications, and Stem Cell Biology), by End Us

3D Cell Culture Market, by Technology (Extracellular Matrices or Scaffolds, Bioreactors, Gels, Scaffold-free Platforms, and Microchips), by Application (Research, Drug Discovery, Tissue Engineering, Clinical Applications, and Stem Cell Biology), by End User (Research Labs & Institutes, Biopharmaceutical Industry, Hospitals And Diagnostic Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

A 3D cell culture is an in-vitro technique wherein the cells can grow in an artificially created environment. These environments closely resemble to the architecture and functioning of the native tissue. 3D cell culture technique helps stimulate cell differentiation, proliferation, and migration by interacting with their three-dimensional surroundings, as they would in the in-vivo environment. As 3D cell cultures can mimic the structure, activity, and microenvironment of the in-vivo tissues, this technique has varied applications in the fields of drug screening, regenerative medicine, stem cell therapies, and cancer research and cell biology.
Market Dynamics
Key players operating in the global 3D cell culture market are focusing on adoption of inorganic growth strategies such as acquisitions, and collaborations, which are expected to drive the market growth during the forecast period. For instance, in August 2021, CELLINK AB entered an agreement with the owners of Cytena GmbH to acquire all Cytena shares for a purchase price of US$ 36.4 million. The acquisition is in line with CELLINK’s commercial strategy, strengthening CELLINK’s product offering and providing a more complete 3D cell culturing solution. Furthermore, in June 2018, Greiner Bio-One North America, Inc. acquired 3D Cell Culture Technology assets previously owned by Nano 3D Biosciences, Inc. This strategic acquisition aims for the potential growth in the 3D cell culture market with laboratories and research facilities utilizing this new technology daily to find cures for disease and improve the existing cell culture methodology. Furthermore, in December 2021, Allevi and Lonza announced a strategic collaboration to bring the elements needed for 3D bioprinting together. Combining Lonza’s primary cells and media with Allevi’s 3D bioprinters and bioink production capabilities will empower researchers with the tools needed for plug-and-play bioprinting.
Key features of the study:
This report provides in-depth analysis of the global 3D cell culture market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global 3D cell culture market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Lonza, Merck KGaA, 3D Biotek LLC, 3D Biomatrix, Inc., 3D Biomatrix, Inc., and REPROCELL Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global 3D cell culture market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global 3D cell culture market
Detailed Segmentation:
Global 3D Cell Culture Market, By Technology:
Extracellular Matrices or Scaffolds
Bioreactors
Gels
Scaffold-free Platforms
Microchips
Global 3D Cell Culture Market, By Application
Research
Drug Discovery
Tissue Engineering
Clinical Applications
Stem Cell Biology
Global 3D Cell Culture Market, By End User:
Research Labs & Institutes
Biopharmaceutical Industry
Hospitals And Diagnostic Centers
Others
Global 3D Cell Culture Market, By Region:
North America
By Technology:
Extracellular Matrices or Scaffolds
Bioreactors
Gels
Scaffold-free Platforms
Microchips
By Application
Research
Drug Discovery
Tissue Engineering
Clinical Applications
Stem Cell Biology
By End User:
Research Labs & Institutes
Biopharmaceutical Industry
Hospitals And Diagnostic Centers
Others
By Country
U.S.
Canada
Latin America
By Technology:
Extracellular Matrices or Scaffolds
Bioreactors
Gels
Scaffold-free Platforms
Microchips
By Application
Research
Drug Discovery
Tissue Engineering
Clinical Applications
Stem Cell Biology
By End User:
Research Labs & Institutes
Biopharmaceutical Industry
Hospitals And Diagnostic Centers
Others
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Technology:
Extracellular Matrices or Scaffolds
Bioreactors
Gels
Scaffold-free Platforms
Microchips
By Application
Research
Drug Discovery
Tissue Engineering
Clinical Applications
Stem Cell Biology
By End User:
Research Labs & Institutes
Biopharmaceutical Industry
Hospitals And Diagnostic Centers
Others
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Technology:
Extracellular Matrices or Scaffolds
Bioreactors
Gels
Scaffold-free Platforms
Microchips
By Application
Research
Drug Discovery
Tissue Engineering
Clinical Applications
Stem Cell Biology
By End User:
Research Labs & Institutes
Biopharmaceutical Industry
Hospitals And Diagnostic Centers
Others
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Technology:
Extracellular Matrices or Scaffolds
Bioreactors
Gels
Scaffold-free Platforms
Microchips
By Application
Research
Drug Discovery
Tissue Engineering
Clinical Applications
Stem Cell Biology
By End User:
Research Labs & Institutes
Biopharmaceutical Industry
Hospitals And Diagnostic Centers
Others
By Country
GCC
Israel
Rest of Middle East
Africa
By Technology:
Extracellular Matrices or Scaffolds
Bioreactors
Gels
Scaffold-free Platforms
Microchips
By Application
Research
Drug Discovery
Tissue Engineering
Clinical Applications
Stem Cell Biology
By End User:
Research Labs & Institutes
Biopharmaceutical Industry
Hospitals And Diagnostic Centers
Others
By Country/Region
North Africa
Central Africa
South Africa
Company Profiles
Becton, Dickinson and Company*
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategy
Thermo Fisher Scientific Inc.
Lonza
Merck KGaA
3D Biotek LLC
3D Biomatrix, Inc.
InSphero AG
REPROCELL Inc.
“*” marked represents similar segmentation in other categories in the respective section.